Should You Sell DermTech and GoodRx Stocks Right Now?

DermTech (NASDAQ: DMTK) and GoodRx (NASDAQ: GDRX) have been huge losers for investors over the last 12 months. In this Motley Fool Live video, recorded on Jan. 12., Fool contributors Keith Speights and Brian Orelli answer a viewer's question about whether or not it's time to sell these beaten-down healthcare stocks. Brian Orelli: I don't really follow GoodRx all that closely, so maybe you can comment on that one if you do.